BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Heart
,
Personalized medicine
,
Doxycycline
,
rs2476601
,
PPARA
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CX3C chemokine receptor 1
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Monocyte of peripheral blood
Substantia nigra
Nodose nucleus
Myeloid cells of peripheral blood
Whole blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Listeriosis
Meningitis
Shock
Pulmonary hypertension
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
FluMist
fluarix
buparvaquone
olive oil
Recombinant Fusion Proteins
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
ARID5B
TRAF2
USP18
IKZF3
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Spatio-temporal transcriptome of the human brain
Whole blood gene expression of intubated subjects undergoing mechanical ventilation
PBMC from critical COPD patients compared to healthy controls
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for CX3C chemokine receptor 1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis
Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ